Categories: The Charlton Centre

Are You Ready to Quit?

Autoimmune diseases are more common and may also progress at a greater rate amongst those who smoke tobacco. Treatments such as biologics don’t work as well in people who continue to smoke. At Charlton Health we are happy to assist people in quitting smoking.

Heart disease is greater in those who smoke and in conditions with high inflammation, heart disease is also higher than in the general public. Many of the conditions we treat also have potential lung complications, and of course smoking increases lung damage.

For all these reasons, quitting smoking is the best thing a person can do for their health, and even more so for people with the conditions listed above.

This week, as National Non-Smoking Week, is a good time to think about quitting. If you need assistance or strategies, or a better understanding of the treatment options available, please reach out to us. We look forward to working with you.

Learn more about National Non-Smoking Week here.


Carolyn Whiskin is the Pharmacy Manager for Charlton Health.  Carolyn specializes in the treatment of autoimmune diseases, pharmaceutical compounding, women’s health, pain and smoking cessation. Carolyn has won provincial and national awards for her commitment to patient care and public service.

admin

Share
Published by
admin

Recent Posts

Happy Back-to-School!

This week, many will return to school, and it's no secret that the back-to-school season…

1 week ago

Staying Hydrated in the Summer

Staying well hydrated is important in every season, but it becomes especially crucial during thesummer.…

3 weeks ago

World Hepatitis Day

Last week, on July 28th, we observed World Hepatitis Day, a day dedicated to raising…

1 month ago

Traveling This Summer with Biologics? Here’s What You Need to Know

Summer is a great time to get out and see new sights. Whether you're planning…

2 months ago

Summer Sun Safety

Now that the warmer weather is here, many of us are spending more time enjoying…

2 months ago

New Biosimilars of Xolair and Actemra Now Available: Omlyclo and Tyenne

Biosimilars are becoming more common in Canada, offering patients trusted alternatives to the originator biologic medication. Biosimilars…

3 months ago